Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration. (Q47738746)

From Wikidata

Jump to navigation Jump to search

scientific article published on 10 April 2009

Language	Label	Description	Also known as
English	Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.	scientific article published on 10 April 2009

Statements

scholarly article

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration. (English)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

influenza vaccine

1 reference

based on heuristic

inferred from title

9

object named as

Jaap Goudsmit

1 reference

Europe PubMed Central

5 February 2018

author name string

Valérie Künzi

1

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

Jaco M Klap

2

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

Michael K Seiberling

3

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

Christian Herzog

4

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

Katharina Hartmann

5

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

Oliver Kürsteiner

6

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

Ronald Kompier

7

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

Roberto Grimaldi

8

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

language of work or name

0 references

publication date

10 April 2009

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

27

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

3561-3567

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

27

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

Influenza: its control in persons and populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Influenza virus infections in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Economic impact of influenza vaccination in preschool children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Clinical and economic impact of influenza vaccination on healthy children aged 2–5 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Effectiveness of virosomal subunit influenza vaccine in preventing influenza-related illnesses and its social and economic consequences in children aged 3-14 years: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

The effectiveness of vaccination against influenza in healthy, working adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Reduced-dose intradermal vaccination against hepatitis A with an aluminum-free vaccine is immunogenic and can lower costs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Serum antibody responses after intradermal vaccination against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Dose sparing with intradermal injection of influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Antibody responses after dose-sparing intradermal influenza vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Comparative immunogenicity of trivalent influenza vaccine administered by intradermal or intramuscular route in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Inflexal V a trivalent virosome subunit influenza vaccine: production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Is it time to give influenza vaccine to healthy infants?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.03.062

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.03.062

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

1 reference

Europe PubMed Central

5 February 2018

http://europepmc.org/abstract/MED/19464535

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47738746&oldid=1775339420"